Can Virtual Reality Technology Improve the Patient Experience in Oocyte Retrieval?
A non-pharmacological, non-blinded, randomized cohort study that will investigate the effect of Virtual Reality technology on the patient experience during oocyte retrieval.
The primary objective of the trial is to investigate the impact of Virtual Reality technology on the patient experience
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Skive, Denmark, 7800
- Recruiting
- Fertility Clinic Skive, Skive Regional Hospital
-
Contact:
- Peter Humaidan, DMSc
- Phone Number: +4578445760
- Email: fertilitetsklinikken@midt.rm.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women undergoing oocyte retrieval
- Understanding and speaking Danish
Exclusion Criteria:
- Previous participation in the trial
- Acupuncture as pain relief during oocyte retrieval
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual reality
The intervention group receives stimuli in the form of Virtual Reality technology before and during oocyte retrieval.
In addition, patients receive standard treatment
|
Participants who are randomized to group 1 will receive the Virtual Reality glasses on the day of oocyte retrieval in the recovery room.
The participant chooses which animation she wants to experience.
|
|
No Intervention: Control
The control group, does not receive stimuli in the form of Virtual Reality technology, but only the standard treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaires regarding impact on patient experience
Time Frame: 30-60 minutes
|
The impact of Virtual Reality technology on the patient experience during oocyte retrieval through questionnaires. A visual analog scale (VAS) from 1-10 will be used for this measurement. |
30-60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaires reagarding the impact on the consumption of analgesic medication
Time Frame: 30-60 minutes
|
The effect of Virtual Reality technology on the consumption of analgesic medication. A visual analog scale (VAS) from 1-10 will be used for this measurement. |
30-60 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Virtual Reality-project
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.